Tonix Pharmaceuticals Holding Corp.

NasdaqCM:TNXP Stock Report

Market Cap: US$24.9m

Tonix Pharmaceuticals Holding Balance Sheet Health

Financial Health criteria checks 5/6

Tonix Pharmaceuticals Holding has a total shareholder equity of $42.1M and total debt of $8.5M, which brings its debt-to-equity ratio to 20.2%. Its total assets and total liabilities are $70.3M and $28.2M respectively.

Key information

20.2%

Debt to equity ratio

US$8.49m

Debt

Interest coverage ration/a
CashUS$4.16m
EquityUS$42.10m
Total liabilitiesUS$28.20m
Total assetsUS$70.31m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: TNXP's short term assets ($25.3M) exceed its short term liabilities ($22.0M).

Long Term Liabilities: TNXP's short term assets ($25.3M) exceed its long term liabilities ($6.2M).


Debt to Equity History and Analysis

Debt Level: TNXP's net debt to equity ratio (10.3%) is considered satisfactory.

Reducing Debt: TNXP's debt to equity ratio has increased from 0% to 20.2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TNXP has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: TNXP is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies